Eric Westin, M.D.
Chief Medical Officer

Eric Westin, M.D., is the chief medical officer of Bicycle Therapeutics.

Eric has more than 40 years of experience in oncology research and drug development. Prior to joining Bicycle Therapeutics, Eric was vice president of clinical development and translational sciences of ImmunoGen, a biotechnology company focused on the development of antibody-drug conjugate therapeutics for the treatment of cancer, through its acquisition by AbbVie. He also held roles of increasing responsibility at Takeda Pharmaceuticals, Takeda Oncology (a subsidiary of Takeda Pharmaceuticals) and Lilly. Prior to joining industry, Eric supported clinical trials at the National Institutes of Health, was a professor of medicine at West Virginia University and Virginia Commonwealth University and served in the U.S. Public Health Service.

Eric earned a B.S. in biology from Rensselaer Polytechnic Institute and an M.D. from Albany Medical College and holds board certifications in internal medicine and medical oncology. He is an author on more than 100 peer-reviewed scientific publications and is a member of the American Society for Clinical Oncology, the American Association for Cancer Research and the American Society of Hematology.